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MEGXAbstract Objectives: To estimate plasma monoethylglycinexylidide (MEGX) level at 15 and
30 min after intravenous injection of lidocaine as a measure for detoxiﬁcation and excretory func-
tion of the liver in cirrhotic patients in comparison with non-cirrhotic patients assigned for laparo-
scopic cholecystectomy (LC).
Patients and methods: The study included 50 cirrhotic and 10 non-cirrhotic patients assigned for
LC. Only Child-Pugh (CP) class A or B patients with adjusted liver functions were included in
the study. Both patients and controls received anesthesia using a similar protocol. Intravenous lido-
caine (1 mg/kg) was injected over 1 min, and blood samples were obtained immediately before lido-
caine injection (S0) to assure absence of MEGX in plasma and 15 min (S15) and 30 min (S30) after
lidocaine administration. MEGX values > 90 ng/ml are considered normal. The extent of MEGX
extraction was calculated as plasma MEGX level at S30 minus S15.
Results: Mean operative and anesthesia times were 59.3 ± 10.4 and 73.9 ± 12.2 min, respectively.
Mean sevoﬂurane 18.1 ± 2.4 ml/h. Operative and anesthetic data showed non-signiﬁcant difference
between patients categorized according to CP class and in comparison with controls. Estimated
plasma MEGX levels at 15-min and 30-min after lidocaine injection were signiﬁcantly higher in
controls compared to patients and in patients of CP class A compared to those of class B. The
68 A.A. Mohamed et al.extent of extraction was signiﬁcantly lower in patients of CP class B compared both to controls and
patients of class A with non-signiﬁcantly lower extraction level in patients of class A compared to
controls.
Conclusion: Laparoscopic cholecystectomy is safe and feasible in cirrhotic patients and MEGX test
as a measure of detoxiﬁcation and excretory function of the liver is a reliable test that showed a
relationship to the extent of hepatic derangement.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Cirrhosis causes a hyperdynamic circulation with increased
cardiac output and decreased systemic vascular resistance;
however, it endangers hepatic circulation in the form of de-
creased venous perfusion secondary to reduced portal blood
ﬂow as a consequence of portal hypertension. Also, hepatic
arterial blood ﬂow can be decreased because of impaired auto-
regulation [1,2].
The burden of operative risk on the liver is dependent on
both the underlying liver disease, type of surgery, operative
approach, and duration. Anesthetics increase the burden on
hepatic blood ﬂow in the form of reduced hepatic blood ﬂow
by 30–50%, but agents such as isoﬂurane, desﬂurane, sevoﬂu-
rane, and propofol cause less perturbation in hepatic arterial
blood ﬂow than other inhaled anesthetic agents and so are pre-
ferred for patients with liver disease. Traction on abdominal
viscera may cause reﬂex dilatation of splanchnic veins and
thereby lower hepatic blood ﬂow [3–5].
Dynamic tests are related to the ability of the liver to metab-
olize or eliminate deﬁned substances in a given time. Thus, dy-
namic tests have the advantage of quantifying the functional
status at the time point of assessment. Historically, the bromo-
sulfophthalein and indocyanine green tests have been used as
dynamic function tests. Unfortunately, these tests are no longer
used because of lack of commercial availability of bromosul-
ophthalein and high cost of indocyanine green [6,7].
Lignocaine is a compoundwith a high hepatic extraction and
an oxidative metabolic pathway catalyzed by the hepatic P450
IIIA4 cytochrome yielding monoethylglycinexylidide (MEGX).
Estimation of plasma MEGX levels after intravenous injection
of lignocaine constitutes a simple dynamic liver function test.
The idea behind this test is to detect reduced clearance of lido-
caine in cases of liver diseases or reduced hepatic blood ﬂow
by measurement of plasma MEGX. Reduced liver function or
hepatic blood ﬂow results in reduced formation of MEGX in
humans. This test has the advantage that it is easy to do [7,8].
The current prospective study aimed to estimate plasma
MEGX level at 15 and 30 min after intravenous injection of
lidocaine as a measure for detoxiﬁcation and excretory
function of the liver in cirrhotic patients in comparison
with control non-cirrhotic patients assigned for laparoscopic
cholecystectomy.
2. Patients and methods
The current prospective comparative study was conducted at
Anesthesia Department, Kasr Al-Eini University Hospital
since Jan 2009 till June 2012. After approval of the study pro-
tocol by the Local Ethical Committee and obtaining fully
informed written patients’ consent, 50 cirrhotic patients as-
signed for laparoscopic cholecystectomy (LC) were enrolledin the study. For comparative purposes, 10 non-cirrhotic,
age-, and sex-matched controls assigned for LC were enrolled
in the study.
Inclusion criteria included cirrhotic patients whose hospital
ﬁles included the required preoperative data especially liver
function tests, abdominal ultrasonography, and their baseline
Child-Pugh (CP) class. Only patients with adjusted liver func-
tions and were CP class A or B were included in the study. Pa-
tients with clinically detectable ascites or had history of or
deﬁned obstructive jaundice or recent attack of gastrointestinal
bleeding were excluded from the study. Both study and control
groups received anesthesia using a similar protocol. Atropine
0.2 mg and midazolam 0.03 mg/kg were administered IV be-
fore induction of anesthesia. Anesthesia was induced with fen-
tanyl 1–2 lg/kg and propofol 2 mg/kg Endotracheal
intubation was facilitated by IV atracurium 0.5 mg/kg. Anes-
thesia was maintained with sevoﬂurane in oxygen 3 l/min. Ven-
tilation was controlled to keep PaCO2 between 30 and
40 mmHg. Atracurium was used as a muscle relaxant during
surgery. Non-invasive intraoperative monitoring included
heart rate (HR), systolic, and diastolic blood pressure (SBP
& DBP). After surgery, all patients were extubated and were
followed in ICU for 24 h and thereafter in the surgical ward.
At ICU, heart rate, blood pressure, and oxygen saturation
were monitored continuously with a non-invasive method.2.1. Estimation of serum MEGX
All samples were taken from a plastic cannula on the contra-
lateral arm to that used for the administration of lidocaine.
The cannula was kept patent with a trocar. Blood samples
were drawn into EDTA; plasma was separated within 30 min
and stored at 40 C until analysis. Concentrations of mono-
ethylglycinexylidide (MEGX) were analyzed with gas chroma-
tography using etidocaine as an internal standard [9].
Intravenous lidocaine was injected in a sub-therapeutic
dose (1 mg/kg) over 1 min after transfer to ICU. Blood sam-
ples were obtained immediately before lidocaine injection
(S0) to assure absence of MEGX in plasma and 15 min (S15)
and 30 min (S30) after lidocaine administration. MEGX val-
ues > 90 ng/ml are considered normal, whereas values below
50 ng/ml reﬂect impaired liver function and values ranged be-
tween 50 and 90 ng/ml reﬂect affected liver function [9]. The
extent of MEGX produced as a measure for detoxiﬁcation
and excretion functions of the liver was calculated as plasma
MEGX level at S30 minus S15.
2.2. Statistical analysis
Results were presented as mean ± SD, ranges, numbers, per-
centages, and ratios. Data were analyzed using Chi-square test
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test for unrelated data for inter-group comparisons. Statistical
analyses were conducted using SPSS (Version 15, 2006)
program, and p value < 0.05 was considered signiﬁcant.
3. Results
The study included 50 cirrhotic patients; 16 males and 34
females with mean age of 45.4 ± 7.3; range: 33–55 years and
10 controls; 4 males and 6 females with mean age of
45.3 ± 7.2; range: 35–54 years. There were 29 CP class A
patients and 21 CP class B patients. There was non-signiﬁcant
(p> 0.05) difference between patients and controls and
among patients categorized according to CP class as regards
age and gender distribution.
Mean operative time was 59.3 ± 10.4; range: 40–75 min for
patients and was 60.5 ± 6.9; range: 50–70 min for controls.
Mean anesthesia time was 73.9 ± 12.2; range: 53–95 min for
patients and was 74.1 ± 10; range: 60–88 min for controls.
Mean sevoﬂurane consumption was 18.1 ± 2.4; range:
14–22 ml/h, while for controls was 18.4 ± 2.5; range:
15–22 ml/h. Operative and anesthetic data showed non-signif-
icant (p> 0.05) difference between patients categorized accord-
ing to CP class and in comparison with controls (Table 1).
All patients and controls showed signiﬁcantly higher heart
rate and blood pressure measures after insufﬂation compared
to both baseline and post-desufﬂation measures with non-sig-
niﬁcantly higher measures after desufﬂation in comparison
with baseline measures. However, these hemodynamic re-
sponses were similar in both studied groups with non-signiﬁ-
cant difference between patients categorized according to CP
class and between both patients’ groups and controls (Table 2).
Estimated plasma MEGX levels at 15-min and 30-min after
lidocaine injection were signiﬁcantly higher in controls com-
pared to patients categorized according to CP class with signif-
icantly higher plasma MEGX levels in patients of CP class A
compared to those of class B. The extent of extraction was sig-
niﬁcantly lower in patients of CP class B compared both to
controls and patients of class A with non-signiﬁcantly lower
extraction level in patients of class A compared to controls
(Table 3).
4. Discussion
The applicability of routine liver tests could not predict the
anesthetic and surgical burden on liver; considering the abilityTable 1 Operative and anesthetic data.
Control (n= 10) CP class
Operative time (min) 60.5 ± 6.9 59.9 ± 9
(50–70) (43–75)
Anesthesia time (min) 74.1 ± 10 72.6 ± 1
(60–88) (55–89)
Sevoﬂurane consumption (ml/h) 18.4 ± 2.5 18 ± 2.4
(15–22) (14–22)
Data are presented as mean ± SD & ranges are in parenthesis; p1: signiﬁ
class B and controls; p3: signiﬁcance between CP class A and CP class Bof liver for extraction and detoxiﬁcation of certain substance
and excretion of its non-toxic metabolites either in biliary pas-
sages or blood sinusoids is one of the major functions of the
liver and reﬂects its affection by pre-existing diseases or by
risk-exposure [10–12]. MGEX is the major metabolism prod-
uct of lidocaine and considering lidocaine as a substance not
normally synthesized in the body, and subsequently, its metab-
olites are not present in circulation, so its estimation could re-
ﬂect the detoxiﬁcation and extraction function of the liver
[8,13].
All patients and controls showed affection by surgical and
anesthetic effect as manifested by the ﬁnding that none of pa-
tients had 30-min plasma MGEX level P90 ng/ml; while only
3 of control had 30-min plasma MGEX of >90 ng/ml. This
affection could be attributed to the effect imposed by pneumo-
peritoneum on hepatic blood ﬂow and subsequent liver abili-
ties and functions. In support of this assumption,
Nickkholgh et al. [14] experimentally reported that increase
in intraabdominal pressure (IAP) to 12 mmHg signiﬁcantly in-
creased liver enzymes measured after desufﬂation to almost 1.5
times as much as control values and in parallel, in all subacinar
zones the permanent adherence of both leukocytes and plate-
lets to the endothelium increased by about sixfold and three-
fold, respectively, also. Kupffer cells labeled with latex beads
as an index for their activation were signiﬁcantly increased
compared to controls. Also, Eiriksson et al. [15] experimentally
compared raised IAP during laparoscopic hepatectomy to 8 or
16 mmHg and found high IAP reduces the amount of bleeding.
Sa´nchez-Etayo et al. [16] experimentally reported that total li-
ver blood ﬂow remained mostly unaltered at low IAP, but as
IAP increased, a signiﬁcant decline in hepatic microcirculatory
blood ﬂow was observed.
The current study found that the excretory function of liver
was maintained in both classes of cirrhosis as manifested by in-
creased plasma levels of MEGX at 30-min in comparison with
levels estimated at 15-min. However, patients of class A had
more preserved excretory function compared to those of class
B as manifested by a signiﬁcantly higher extent of excretion in
patients of class A compared to patients of class B. These data
indicated a negative relationship between the CP class as a
reﬂection of liver derangement and plasma MEGX level and
so it could be used as a marker for deterioration of liver func-
tion and prediction of outcome.
In line with these ﬁndings, Sakka [17] found MEGX for
lidocaine metabolism as an available dynamic test that may
be recommended in critically ill patients for assessing liverA (n= 29) CP class B (n= 21) Statistical signiﬁcance
.3 58.5 ± 12 Z= 0.283; p1 > 0.05
(40–75) Z= 0.577; p2 > 0.05
Z= 0.179; p3 > 0.05
0 75.7 ± 15 Z= 0.400; p1 > 0.05
(53–95) Z= 0.562; p2 > 0.05
Z= 1.231; p3 > 0.05
18.2 ± 2.4 Z= 1.646; p1 > 0.05
(15–22) Z= 0.604; p2 > 0.05
Z= 1.547; p3 > 0.05
cance between CP class A and controls; p2: signiﬁcance between CP
patients.
Table 2 Hemodynamic data of studied patients recorded after peritoneal insufﬂation and desufﬂation compared to baseline data.
Baseline Post-insuﬄation Post-desuﬄation
HR (beats/min) Controls (n= 10) 78.1 ± 4.9 86.9 ± 4.3 82.5 ± 3.5 Z= 2.670; p4 = 0.008
Z= 1.330; p5 > 0.05
Z= 2.251; p6 = 0.024
CP class A (n= 29) 77.7 ± 3.7 85.5 ± 5.4 81.8 ± 3.9 Z= 2.706; p4 = 0.007
Z= 1.481; p5 > 0.05
Z= 2.814; p6 = 0.024
CP class B (n= 21) 80.7 ± 4.7 85.3 ± 4.7 81.7 ± 5.5 Z= 2.048; p4 = 0.041
Z= 0.309; p5 > 0.05
Z= 3.173; p6 = 0.019
Statistical signiﬁcance Z= 1.693; p1 > 0.05 Z= 0.357; p1 > 0.05 Z= 1.330; p1 > 0.05
Z= 0.707; p2 > 0.05 Z= 1.842; p2 > 0.05 Z= 1.227; p2 > 0.05
Z= 1.228; p3 > 0.05 Z= 0.892; p3 > 0.05 Z= 0.579; p3 > 0.05
SBP (mmHg) Controls (n= 10) 118 ± 8.5 125.3 ± 3 122.2 ± 3 Z= 2.314; p4 = 0.021
Z= 1.376; p5 > 0.05
Z= 2.652; p6 = 0.008
CP class A (n= 29) 120 ± 4.5 125.3 ± 3.3 123.9 ± 4.5 Z= 3.555; p4 < 0.001
Z= 3.531; p5 > 0.01
Z= 2.922; p6 = 0.023
CP class B (n= 21) 119 ± 4 124.1 ± 3.6 122.8 ± 4.2 Z= 3.377; p4 = 0.001
Z= 2.818; p5 > 0.05
Z= 2.438; p6 = 0.024
Statistical signiﬁcance Z= 2.023; p1 > 0.05 Z= 1.027; p1 > 0.05 Z= 1.756; p1 > 0.05
Z= 1.226; p2 > 0.05 Z= 0.793; p2 > 0.05 Z= 1.989; p2 > 0.05
Z= 1.125; p3 > 0.05 Z= 0.457; p3 > 0.05 Z= 0.789; p3 > 0.05
DBP (mmHg) Controls (n= 10) 74.5 ± 3 79.6 ± 3.6 77.7 ± 6.9 Z= 2.670; p4 = 0.008
Z= 1.330; p5 > 0.05
Z= 2.251; p6 = 0.024
CP class A (n= 29) 73.8 ± 2.3 80 ± 4.9 76.8 ± 4.5 Z= 2.706; p4 = 0.007
Z= 1.481; p5 > 0.05
Z= 2.814; p6 = 0.024
CP class B (n= 21) 74.7 ± 3.4 79.9 ± 6.5 77.1 ± 5.2 Z= 2.048; p4 = 0.041
Z= 0.309; p5 > 0.05
Z= 2.473; p6 = 0.024
Statistical signiﬁcance Z= 1.693; p1 > 0.05 Z= 0.357; p1 > 0.05 Z= 1.330; p1 > 0.05
Z= 0.707; p2 > 0.05 Z= 1.842; p2 > 0.05 Z= 1.227; p2 > 0.05
Z= 1.228; p3 > 0.05 Z= 0.892; p3 > 0.05 Z= 0.579; p3 > 0.05
Data are presented as mean ± SD; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; p1: signiﬁcance between CP
class A and controls; p2: signiﬁcance between CP class B and controls; p3: signiﬁcance between CP class A and CP class B patients; p4:
signiﬁcance between baseline and post-insufﬂation levels; p5: signiﬁcance between baseline and post-desufﬂation levels; p6: signiﬁcance between
post-insufﬂation and post-desufﬂation levels.
Table 3 Plasma MEGX levels estimated at 15-min and 30-min after lidocaine injection.
15-min level 30-min level Extent of extraction
Controls (n= 10) 77.6 ± 5.4 (65–84) 85.3 ± 5.3 (75–83) Z= 2.809; p4 = 0.005 7.7 ± 2.2 (5–11)
CP class A (n= 29) 65.3 ± 5.8 (50–78) 70.9 ± 5.5 (54–83) Z= 4.041; p4 > 0.001 5.7 ± 1.7 (2–8)
CP class B (n= 21) 41 ± 6.8 (31–56) 45.4 ± 6 (37–59) Z= 4.723; p4 > 0.001 4.4 ± 1.6 (2–7)
Statistical signiﬁcance Z= 2.812; p1 = 0.005 Z= 2.807; p1 = 0.005 Z= 1.672; p1 > 0.05
Z= 4.018; p2 < 0.001 Z= 4.016; p2 < 0.001 Z= 2.814; p2 = 0.005
Z= 2.397; p3 = 0.017 Z= 2.603; p3 = 0.009 Z= 2.089; p3 = 0.007
Data are presented as mean ± SD; p1: signiﬁcance between CP class A and controls; p2: signiﬁcance between CP class B and controls; p3:
signiﬁcance between CP class A and CP class B patients; p4: signiﬁcance between 15-min and 30-min levels.
70 A.A. Mohamed et al.function, liver blood ﬂow, and cell function. Also, Bhise and
Dias [18] reported that MEGX test is more discriminatory
and recognizes early damage to the liver than conventional
individual liver function tests. Hofmann et al. [19] reportedthat dynamic tests as indocyanine green clearance and MEGX
clearance tests can provide additional information on the ex-
pected residual hepatic function in patients with CP class A cir-
rhosis. Pe´rez-Guille´ et al. [20] experimentally suggested that
Monoethylglycinexylidide Extraction Level as a measure of Hepatic Detoxiﬁcation 71the ratio of MEGX/lidocaine obtained 30 min after lidocaine
administration could be a good marker of hepatic metabolic
function.
In line with the applicability of MEGX test for prediction
of patient’s outcome, Botta et al. [21] found MEGX serum lev-
els were signiﬁcantly different among patients who survived
and those who died and were independently associated with
six month mortality. Lorf et al. [22] found that MEGX-test,
especially the 30 min value, is a useful medium to estimate
the liver reserve in non-cirrhotic patients prior to liver resec-
tion, and in combination with the resection volume, it may
be very useful to identify patients with a high risk of develop-
ing a postoperative liver failure. Laviolle et al. [23] assessed li-
ver function recovery after partial hepatectomy using MEGX
plasma level estimated 15 min after lidocaine injection on
day 2 after surgery and found that estimation of MEGX cor-
relate with liver function outcome.
In support of the correlation between plasma MEGX and
extent of liver injury, Ben Said et al. [24] developed an
ex vivo functional assay to assess liver metabolic capacity
adapted from the lidocaine test in rats and found that both
lidocaine metabolism and MEGX formation levels were signif-
icantly altered in all models of hepatic injury and the extent of
hepatic damage was conﬁrmed by increased trans-aminase lev-
els and alteration of hepatocyte’s structure with areas of
necrosis.
5. Conclusion
It could be concluded that laparoscopic cholecystectomy under
general inhalational anesthesia is safe and feasible in cirrhotic
patients and MEGX test as a measure of liver detoxiﬁcation
and excretory function is a reliable test that showed a relation-
ship to the extent of hepatic derangement.
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